Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 3 3Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Head & Neck 1Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Urothelial Carcinoma 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Transurethral Resection of Bladder × Genitourinary × Clear all
NCT05521698 2026-05-05

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

University of Wisconsin, Madison

Phase 1 Recruiting
80 enrolled
Genitourinary

Non-Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡